With FDCPA and FCRA claims on the rise, and UDAAPs around every corner, it is critical that your company know and understand regulations, and that you are compliant with them as well.
Join Foley for a daylong Web conference, where we will discuss the top regulations that financial institutions need to be aware of and compliant with in today’s heavily regulated financial environment.
- Get up to date on the CFPB’s latest rule changes
- Ensure compliance with RESPA and TILA
- Avoid FDCPA, TCPA, and FCRA claims
- Ensure your financial institution is in line with the EFTA and SCRA
Who Should Attend
This program is designed for attorneys. Bankers, compliance officers, and paralegals may also benefit.
Course Content
- The Consumer Financial Protection Bureau (CFPB)
- Real Estate Settlement Procedures Act (RESPA)
- Truth in Lending Act (TILA)
- Fair Debt Collection Practices Act (FDCPA)
- Telephone Consumer Protection Act (TCPA)
- Unfair, Deceptive or Abusive Acts or Practices (UDAAP)
- Fair Credit Reporting Act (FCRA)
- Electronic Fund Transfer Act (EFTA)
- Servicemembers Civil Relief Act (SCRA)
Registration for this program, presented through the National Business Institute, is $339.
People
Related Insights
June 6, 2025
Energy Current
House Bill 3809 Adds Obligations to Battery Energy Storage Lessees in Texas
On May 29, 2025, House Bill No. 3809 was signed into law by Texas Governor Greg Abbott. Born out of a crop of bills regulating renewable…
June 23, 2025
Events
Third Annual Transaction Solutions Symposium
Foley & Lardner is sponsoring the Third Annual Transaction Solutions Symposium — a premier conference focused on de-risking strategies that enhance deal execution and business outcomes. Rishi Sodhi will be speaking as part of the Tax Liability Insurance: Current Trends, Controversies and Claims panel.
June 5, 2025
Health Care Law Today
GLP-1 Compounded Medications Targeted by Connecticut Attorney General
On May 21, 2025, the Connecticut Office of the Attorney General released a statement and sent letters to Connecticut weight loss clinics, med spas, medical practices and other businesses regarding allegedly or potentially unfair and deceptive conduct relating to compounded GLP-1 medications.